Filing Flows

Filing Flows › Ginkgo Bioworks Holdings (DNA) › Who owns the stock

Who owns Ginkgo Bioworks Holdings (DNA) stock

176 funds reported Ginkgo Bioworks Holdings (DNA) shares in their latest 13F filings, worth $389M in all. The largest holder is BlackRock ($42.4M). Last quarter 84 funds added to their stakes and 51 cut them.

Largest holders of DNA (13F)Largest holders of DNA (13F)BlackRock$42.4MViking Global Investors LP$35.4MErste Asset Management GmbH$25.9MVanguard Group$24.1MBaillie Gifford$23.7MVanguard Capital Management LLC$20.7MAnchorage Capital Group, L.L.C.$17.3MLegal & General Group$16.5MState Street$14.6MForbes J M & Co LLP$12.5M

Largest holders (13F)

FundSharesValueChangeQuarter
BlackRock4,282,903$42.4Mincrease2026-06-30
Viking Global Investors LP3,577,128$35.4Munchanged2026-06-30
Erste Asset Management GmbH2,536,939$25.9Mincrease2026-06-30
Vanguard Group2,900,952$24.1Mincrease2025-12-31
Baillie Gifford2,391,649$23.7Munchanged2026-06-30
Vanguard Capital Management LLC2,087,293$20.7Mincrease2026-06-30
Anchorage Capital Group, L.L.C.1,746,363$17.3Munchanged2026-06-30
Legal & General Group1,669,419$16.5Mincrease2026-06-30
State Street1,472,370$14.6Mincrease2026-06-30
Forbes J M & Co LLP977,371$12.5Mdecrease2026-09-30
Geode Capital Management, LLC1,222,016$12.1Mincrease2026-06-30
Vanguard Portfolio Management LLC937,803$9.3Mincrease2026-06-30
Allianz Asset Management GmbH785,798$7.8Mincrease2026-06-30
UBS Group AG691,659$6.9Mincrease2026-06-30
Barclays511,416$6.6Mincrease2026-09-30

Ginkgo Bioworks Holdings' latest quarter

Ginkgo Bioworks Holdings, Q2 2026: revenue $20.2M (-48% year over year), operating margin -290.5%, net loss $46.7M, operating cash flow −$44.3M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most DNA stock?

By the latest 13F filings: BlackRock ($42.4M); Viking Global Investors LP ($35.4M); Erste Asset Management GmbH ($25.9M); Vanguard Group ($24.1M); Baillie Gifford ($23.7M).

What is the short interest in DNA?

8,294,322 shares were sold short at the 2026-10-15 settlement, 13.38% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.